BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 21, 2008
View Archived Issues
NeuroHealing receives grant from FDA for development of NH-001
Read More
Adjuvanted DNA vaccination against H5N1 influenza induces antibody response
Read More
Experimental lupus improved by bortezomib treatment
Read More
New anticancer agents described in recent patent literature
Read More
Phase II study of MBP-8298 clears DSMB review
Read More
Irribow approved in Japan for irritable bowel syndrome in men
Read More
Astellas Pharma's Graceptor approved in Japan for prevention of organ rejection
Read More
Nasonex receives Japanese approval for treatment of allergic rhinitis in adults
Read More
Raptor enters collaboration with UC for phase IIa clinical trial of cysteamine in NASH
Read More
Novartis to initiate phase III trial of Antisoma's ASA-404 in NSCLC
Read More
EpiCept and GNI enter license agreement for EP-1013
Read More
Boehringer licenses drug targets under autoimmune collaboration with Galapagos
Read More
MRCT and Biolex successfully complete collaboration to humanize BLX-301
Read More
sanofi-aventis to collaborate with Johns Hopkins University on respiratory diseases
Read More
ImmuneRegen reports results from genotoxicity studies of Homspera
Read More
Roche's novel Aurora kinase inhibitor shows promising preclinical profile
Read More
U.K. Ministry of Defense to initiate animal efficacy studies of ALS-886 in lung injury
Read More
Study investigates cardiac safety profile of antimuscarinic drugs for overactive bladder
Read More
Bradmer reports progression-free survival data from phase II trials of Neuradiab in GBM
Read More
Biovest announces results for BiovaxID in non-Hodgkin's lymphoma trial
Read More
EMEA grants orphan medicinal product designation to ProtAffin's PA-401
Read More
Hemantane improves symptoms of Parkinson's disease in an open-label study
Read More
Merrion enters next stage of oral drug collaboration program with Novo Nordisk
Read More
Teva signs definitive agreement to acquire Barr
Read More